Nadeem I. Chaudhry
FDA investigator
Appears on 6 documents from 2010 to 2020, mostly at sites in India. Most often cites testing and approval or rejection of components, drug product containers, and closures (21 CFR 211.84).
- 6
- Documents on file
- 3.5
- Observations per 483
- 2010
- First seen
- 2020
- Most recent
What they cite most
From 21 observations- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures3
- 21 CFR 118.4Salmonella Enteritidis (SE) prevention measures2
- 21 CFR 211.101Charge-in of components2
- 21 CFR 211.165Testing and release for distribution2
- 21 CFR 211.188Batch production and control records2
- 21 CFR 211.46Ventilation, air filtration, air heating and cooling2
Activity by year
2010: 1, 2015: 2, 2017: 1, 2019: 1, 2020: 1
Where
India 3 · China 1 · France 1 · Ohio 1
Often inspects with
Is Nadeem I. Chaudhry coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
6 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2020-01-24 | 483 Sun Pharmaceutical Industries LimitedJan 24, 2020 · Ahilyanagar, India | Ahilyanagar, India | 1 | |
| 2019-02-01 | 483 Rxhomeo Private LimitedFeb 1, 2019 · Hyderabad, India | Hyderabad, India | 10 | |
| 2017-12-01 | 483 Par Active Technologies Private LimitedDec 1, 2017 · Alathur, India | Alathur, India | 3 | |
| 2015-06-09 | 483 Astrea MontsJun 9, 2015 · Monts, France | Monts, France | 3 | |
| 2015-01-26 | 483 Chongqing Kangle Pharmaceutical Co., Ltd No 4 Huazhong Road, Chongqing, Chemical Industrial ParkJan 26, 2015 · Chongqing (Changshou), China | Chongqing (Changshou), China | 2 | |
| 2010-09-28 | 483 Ohio Fresh Eggs, LLCSep 28, 2010 · Johnstow n, Ohio | Johnstow n, Ohio | 2 |
About this profile
What does Nadeem I. Chaudhry inspect?
Nadeem I. Chaudhry appears on 6 documents on file covering 6 sites, mostly in India.
What do they cite most often?
21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures), followed by 21 CFR 118.4 and 21 CFR 211.101.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Nadeem I. Chaudhry is dated Jan 24, 2020.